Remedent, Inc.
REMI
$0.05
$0.000.00%
| 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 35.04% | -74.99% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.04% | -74.99% | -- | -- | -- |
| Cost of Revenue | 75.16% | -54.83% | -- | -- | -- |
| Gross Profit | 9.60% | -83.41% | -- | -- | -- |
| SG&A Expenses | -18.06% | -79.47% | -- | -- | -- |
| Depreciation & Amortization | -49.04% | -53.73% | -- | -- | -- |
| Other Operating Expenses | 17.54% | -- | -- | -- | -- |
| Total Operating Expenses | 2.26% | -99.71% | -- | -- | -- |
| Operating Income | 105.46% | 158.47% | -- | -- | -- |
| Income Before Tax | 109.67% | -74.71% | -- | -- | -- |
| Income Tax Expenses | -57.14% | -17.65% | -- | -- | -- |
| Earnings from Continuing Operations | 109.25% | -74.75% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00% | 30.48% | -- | -- | -- |
| Net Income | 109.48% | -74.98% | -- | -- | -- |
| EBIT | 105.46% | 158.47% | -- | -- | -- |
| EBITDA | 2,160.00% | 179.15% | -- | -- | -- |
| EPS Basic | 122.56% | -112.67% | -- | -- | -- |
| Normalized Basic EPS | 120.00% | -95.16% | -- | -- | -- |
| EPS Diluted | 119.56% | -115.31% | -- | -- | -- |
| Normalized Diluted EPS | 120.00% | -95.16% | -- | -- | -- |
| Average Basic Shares Outstanding | 0.00% | -25.00% | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
